Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.

about

Sex, Symptom Severity, and Quality of Life in Rheumatology.

P2860

Q47671088-831673C1-D6EC-442C-8F13-20DBDE6EFB50

P2860

Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.

Item

http://www.wikidata.org/entity/Q47778526

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Differential impact of systemi ...... ealth-related quality of life.

@en

Differential impact of systemi ...... ealth-related quality of life.

@nl

type

Item

label

Differential impact of systemi ...... ealth-related quality of life.

@en

Differential impact of systemi ...... ealth-related quality of life.

@nl

prefLabel

Differential impact of systemi ...... ealth-related quality of life.

@en

Differential impact of systemi ...... ealth-related quality of life.

@nl

P1476

Differential impact of systemi ...... health-related quality of life

@en

P2093

Axel Finckh

http://www.w3.org/2001/XMLSchema#string

Benjamin Chaigne

http://www.w3.org/2001/XMLSchema#string

Camillo Ribi

http://www.w3.org/2001/XMLSchema#string

Carlo Chizzolini

http://www.w3.org/2001/XMLSchema#string

Delphine Courvoisier

http://www.w3.org/2001/XMLSchema#string

Swiss Clinical Quality Management Program For Rheumatoid Arthritis

http://www.w3.org/2001/XMLSchema#string

Swiss Systemic Lupus Erythematosus Cohort Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients.

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.

Numerical scoring for the BILAG-2004 index

Novel evidence-based systemic lupus erythematosus responder index.

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.

P2888

s11136-017-1534-4

P304

1767-1775

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11136-017-1534-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Deshiré Alpizar-Rodríguez

P577

2017-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28285445

http://www.w3.org/2001/XMLSchema#string

Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.

about

P2860

P2860

Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698